Testing effectiveness (Phase 2)Looking for participantsNCT06854653What this trial is testingPTX 100 in Patients With Relapsed/Refractory CTCLWho this might be right forCTCL Prescient Therapeutics, Ltd. 115
Testing effectiveness (Phase 2)Study completedNCT00004907What this trial is testingChemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's LymphomaWho this might be right forLymphoma Northwestern University
Testing effectiveness (Phase 2)Study completedNCT00306969What this trial is testingStudy of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell LymphomaWho this might be right forCutaneous T-Cell Lymphoma Boston University 18
Not applicableStudy completedNCT00956475What this trial is testingQuality of Life in Younger Leukemia and Lymphoma SurvivorsWho this might be right forAnxiety DisorderCancer SurvivorFatigue+7 more Case Comprehensive Cancer Center 48
Early research (Phase 1)Ended earlyNCT00096005What this trial is testingTanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or LymphomasWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAIDS-related Peripheral/Systemic LymphomaAnaplastic Large Cell Lymphoma+54 more National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Ended earlyNCT01805037What this trial is testingBrentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ LymphomasWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+114 more Northwestern University 20
Early research (Phase 1)WithdrawnNCT03373305What this trial is testingBrentuximab Vedotin and Lenalidomide in Treating Patients With Relapsed or Refractory T-Cell LymphomasWho this might be right forCD30-Positive Neoplastic Cells PresentFolliculotropic Mycosis FungoidesRecurrent Mycosis Fungoides+4 more City of Hope Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT05956041What this trial is testingPembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell LymphomasWho this might be right forCutaneous T Cell LymphomaFungoides Mycosis Sezary Syndrome University of Michigan Rogel Cancer Center 23
Not applicableStudy completedNCT00993694What this trial is testingMethemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With DapsoneWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+6 more Vanderbilt University 41
Not applicableLooking for participantsNCT07132567What this trial is testingAssessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result SurveillanceWho this might be right forMycosis FungoidesSezary Syndrome Kyowa Kirin Co., Ltd. 15
Early research (Phase 1)Study completedNCT00002765What this trial is testingImmunotoxin in Treating Patients With Leukemia or LymphomaWho this might be right forLeukemiaLymphoma National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00054171What this trial is testingPhotodynamic Therapy in Treating Patients With Lymphoma or Chronic Lymphocytic LeukemiaWho this might be right forLeukemiaLymphoma Roswell Park Cancer Institute 1
Testing effectiveness (Phase 2)Study completedNCT00425555What this trial is testingStudy of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell LymphomaWho this might be right forCutaneous T-Cell Lymphoma Novartis Pharmaceuticals 139
Testing effectiveness (Phase 2)Study completedNCT00002663What this trial is testingBiological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or MalignanciesWho this might be right forEBV-induced LymphomasEBV-associated MalignanciesTransplant Patients With EBV Viremia at High Risk of Developing a Recurrent EBV Lymphoma Atara Biotherapeutics 58
Early research (Phase 1)UnknownNCT00769613What this trial is testingEmergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus InfectionsWho this might be right forCancer Milton S. Hershey Medical Center 20
Very early researchStudy completedNCT00424242What this trial is testingPemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal MetastasesWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more Northwestern University 15
Early research (Phase 1)Study completedNCT00042900What this trial is testingPyroxamide in Treating Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00004241What this trial is testing17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or SarcomaWho this might be right forAIDS-related Peripheral/Systemic LymphomaAIDS-related Primary CNS LymphomaAnaplastic Large Cell Lymphoma+50 more National Cancer Institute (NCI) 60
Early research (Phase 1)Ended earlyNCT01643603What this trial is testingDasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic MalignanciesWho this might be right forNon-Hodgkin's LymphomaHodgkin's LymphomaMyeloid Leukemia+3 more Barbara Ann Karmanos Cancer Institute 5
Not applicableStudy completedNCT00445952What this trial is testingNatural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell TransplantWho this might be right forCancer European Organisation for Research and Treatment of Cancer - EORTC 304